Bicalutamide Tabi Tablet

Bicalutamide Tabi Tablet Specification

Usage
Hospital

Storage
Dry Place

Grade
Pharma

Appearance
Tablets

Dosage
50mg

Bicalutamide Tabi Tablet Trade Information

Minimum Order Quantity
100 Strips

Supply Ability
5000 Strips Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Bicalutamide Tabi Tablet

Bicalutamide Tabi Tablet contains the active ingredient bicalutamide, which is a nonsteroidal antiandrogen medication used primarily in the treatment of prostate cancer. These tablets are indicated for the treatment of metastatic prostate cancer in combination with a luteinizing hormone-releasing hormone (LHRH) analog or surgical castration. It works by blocking the action of androgens (male hormones) like testosterone, thereby slowing the growth and spread of prostate cancer cells. Bicalutamide Tabi Tablet competes with androgens for binding to androgen receptors in prostate cells, thereby inhibiting the growth and proliferation of prostate cancer cells.

Specification

Strength	50 mg
Packaging Size	3 x 10 Tablet
Prescription/Non prescription	Prescription
Manufacturer	Dr Reddy
Packaging Type	Strip
Composition	Bicalutamide USP
Brand	Tabi

Hospital-Grade Oncology Care

Bicalutamide Tabi Tablet is trusted by hospitals for use in cancer treatment regimens due to its consistent quality and efficacy. Each tablet is precisely formulated, supporting healthcare providers in delivering standardized care.

Export Quality Assurance

As a major exporter and wholesaler from India, the producer ensures that every batch of Bicalutamide Tabi 50mg adheres to rigorous pharmaceutical grade standards. This commitment guarantees patient safety and product reliability for global customers.

FAQ's of Bicalutamide Tabi Tablet:

Q: How should Bicalutamide Tabi Tablets be stored to maintain their effectiveness?

A: They should be stored in a dry place, away from moisture and direct sunlight, to preserve their potency and prevent degradation.

Q: What is the recommended dosage of Bicalutamide Tabi Tablet in hospital use?

A: The standard dosage is 50mg per day, as directed by medical professionals for the specific treatment prescribed.

Q: When is Bicalutamide Tabi Tablet typically administered to patients?

A: This medication is generally given once daily, at the same time each day, following a healthcare provider's instructions within a hospital setting.

Q: Where is Bicalutamide Tabi Tablet manufactured and distributed from?

A: It is manufactured and exported from India by reputable wholesalers specializing in high-quality pharmaceutical products.

Q: What is the process for using Bicalutamide Tabi Tablet during cancer therapy?

A: Bicalutamide Tabi is administered orally as part of a targeted cancer treatment plan. The therapy process is managed and monitored by healthcare professionals in hospitals.

Q: What are the main benefits of using Bicalutamide Tabi Tablet for patients?

A: The primary benefit is its effectiveness in managing certain hormone-responsive cancers, supporting disease control and improving clinical outcomes when used under medical supervision.